CITÓMICA
National Cancer Institute
Rockville, Estados UnidosPublicacions en col·laboració amb investigadors/es de National Cancer Institute (10)
2024
-
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
The Lancet Haematology, Vol. 11, Núm. 11, pp. e862-e872
2021
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212
2016
-
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30
2014
-
Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma
Haematologica, Vol. 99, Núm. 7, pp. 1228-1235
2013
-
Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival
Molecular and Cellular Biology, Vol. 33, Núm. 22, pp. 4562-4578
2010
-
Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection
Cytometry Part B - Clinical Cytometry
-
Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1
-
Prevalence of monoclonal B-cell lymphocytosis: A systematic review
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1
2008
-
Flow cytometric immunophenotyping of cerebrospinal fluid
Current Protocols in Cytometry
2007
-
2006 Bethesda international consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications
Cytometry Part B - Clinical Cytometry